Carbon Nanotube Chemist for Fluorescent Peptide Biosensors

CNRS; France; Sur place; EUR 30 000 - 40 000; Plein temps

Résumé du poste

A leading research institution in France is seeking a postdoctoral researcher for a project focused on the development of new nanobiosensors for pancreatic cancer diagnostics. The ideal candidate will hold a PhD, have expertise in materials chemistry and organic synthesis, and be skilled in various molecular characterization techniques. This role involves designing and synthesizing carbon nanotubes and characterizing them using advanced techniques, contributing significantly to cancer biomarker identification and patient stratification strategies. The position is full-time with a starting date in April 2026.

Prestations

Proximity to public transport

Access to analysis platforms

Administrative restaurant nearby

Qualifications

• PhD required, strong background in materials chemistry and organic synthesis.
• Proficient in molecular characterization techniques.
• Independent and well-organized with good interpersonal skills.

Responsabilités

• Design and synthesize new carbon nanotubes functionalized with fluorescent peptides.
• Characterize conjugates using various spectroscopic and microscopic techniques.
• Manage research and coordinate various aspects of work.

Connaissances

Materials chemistry

Organic synthesis

Molecular characterization techniques

Interpersonal skills

Formation

PhD in relevant field

Outils

NMR spectroscopy

FT-IR spectroscopy

XPS

Thermogravimetric analysis

Description du poste

A leading research institution in France is seeking a postdoctoral researcher for a project focused on the development of new nanobiosensors for pancreatic cancer diagnostics. The ideal candidate will hold a PhD, have expertise in materials chemistry and organic synthesis, and be skilled in various molecular characterization techniques. This role involves designing and synthesizing carbon nanotubes and characterizing them using advanced techniques, contributing significantly to cancer biomarker identification and patient stratification strategies. The position is full-time with a starting date in April 2026.